ALTUCCI, Lucia
 Distribuzione geografica
Continente #
NA - Nord America 10.052
EU - Europa 8.607
AS - Asia 3.983
SA - Sud America 716
AF - Africa 53
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 11
Totale 23.434
Nazione #
US - Stati Uniti d'America 9.963
IE - Irlanda 2.690
IT - Italia 1.949
HK - Hong Kong 1.582
SG - Singapore 1.301
UA - Ucraina 1.054
GB - Regno Unito 926
DE - Germania 676
BR - Brasile 663
CN - Cina 534
FI - Finlandia 307
SE - Svezia 278
GR - Grecia 208
TR - Turchia 181
FR - Francia 112
NL - Olanda 75
BE - Belgio 64
KR - Corea 64
IN - India 56
AT - Austria 55
PK - Pakistan 53
VN - Vietnam 48
CA - Canada 46
RU - Federazione Russa 40
ES - Italia 31
HU - Ungheria 27
MX - Messico 24
CZ - Repubblica Ceca 17
ZA - Sudafrica 17
ID - Indonesia 16
RO - Romania 15
BD - Bangladesh 14
IR - Iran 14
AR - Argentina 11
EC - Ecuador 11
IQ - Iraq 11
UZ - Uzbekistan 11
AZ - Azerbaigian 10
EU - Europa 10
SC - Seychelles 10
AE - Emirati Arabi Uniti 9
AU - Australia 9
DK - Danimarca 9
EG - Egitto 9
PT - Portogallo 9
CO - Colombia 8
KZ - Kazakistan 8
NO - Norvegia 8
PL - Polonia 8
IL - Israele 7
MA - Marocco 7
PS - Palestinian Territory 7
AL - Albania 6
AM - Armenia 6
JP - Giappone 6
TW - Taiwan 6
CL - Cile 5
JM - Giamaica 5
JO - Giordania 5
LT - Lituania 5
LV - Lettonia 5
PE - Perù 5
RS - Serbia 5
SI - Slovenia 5
BG - Bulgaria 4
CH - Svizzera 4
KE - Kenya 4
KG - Kirghizistan 4
LA - Repubblica Popolare Democratica del Laos 4
LK - Sri Lanka 4
PY - Paraguay 4
SK - Slovacchia (Repubblica Slovacca) 4
VE - Venezuela 4
DO - Repubblica Dominicana 3
EE - Estonia 3
HR - Croazia 3
IM - Isola di Man 3
NZ - Nuova Zelanda 3
PA - Panama 3
TH - Thailandia 3
TN - Tunisia 3
UY - Uruguay 3
BO - Bolivia 2
CR - Costa Rica 2
CU - Cuba 2
HN - Honduras 2
LB - Libano 2
PH - Filippine 2
QA - Qatar 2
SA - Arabia Saudita 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TJ - Tagikistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
CY - Cipro 1
DZ - Algeria 1
GE - Georgia 1
GT - Guatemala 1
KH - Cambogia 1
Totale 23.428
Città #
Dublin 2.676
Jacksonville 1.619
Santa Clara 1.612
Hong Kong 1.573
Chandler 1.204
Wilmington 578
Chicago 539
Singapore 418
Princeton 362
Falls Church 341
Caserta 303
Medford 286
Boardman 252
Naples 243
Roxbury 243
Ann Arbor 211
New York 192
Beijing 160
San Mateo 132
Bremen 114
Cambridge 102
The Dalles 101
Napoli 99
Woodbridge 97
Aversa 91
Munich 79
Mountain View 76
Des Moines 70
Rome 68
Brussels 62
Ashburn 59
Nanjing 59
São Paulo 50
Los Angeles 45
Dong Ket 44
Milan 42
Nuremberg 40
Seoul 38
Venice 37
Düsseldorf 36
Norwalk 34
Vienna 33
Lappeenranta 30
Helsinki 28
Houston 27
Jinan 26
Ercolano 23
Rio de Janeiro 23
Auburn Hills 21
Redwood City 21
Elora 20
Istanbul 20
Amsterdam 18
Shenyang 18
Belo Horizonte 17
Stuttgart 17
Afragola 16
Falkenstein 16
Fisciano 16
Guangzhou 15
Airola 14
Hangzhou 14
London 14
Tianjin 14
Groningen 13
Salerno 13
West Jordan 13
Zhengzhou 13
Ferrara 12
Jakarta 12
Shanghai 12
Changsha 11
Council Bluffs 11
Curitiba 11
Hanover 11
Lilienthal 11
Madrid 11
Moscow 11
Nanchang 11
Porto Alegre 11
Seattle 11
St Petersburg 11
Volla 11
Brno 10
Fairfield 10
Kunming 10
San Giuseppe Vesuviano 10
Secaucus 10
Tashkent 10
Baku 9
Dongguan 9
Guarulhos 9
Hebei 9
Newark 9
Paris 9
Ribeirão Preto 9
San Giorgio a Cremano 9
Brasília 8
Fortaleza 8
Lisbon 8
Totale 15.224
Nome #
Epigenetic mechanisms underlying prostate cancer radioresistance 1.341
NETosis in pathologies: a preliminary study for NETs detection in vitro 167
Bisphenol A induces cell cycle arrest in primary and prostate cancer cells through EGFR/ERK/p53 signaling pathway activation. 153
D-ribose-glycation of insulin prevents amyloid aggregation and produces cytotoxic adducts 126
Anticancer activities of anthocyanin extract from genotyped Solanum tuberosum L. "Vitelotte" 115
Amelioration of diastolic dysfunction by dapagliflozin in a non-diabetic model involves coronary endothelium 109
C-Myc modulation and acetylation is a key HDAC inhibitor target in cancer 107
Molecular Profiling of Human Primary Chondrosarcoma-Derived Spheres Reveals Specific and Target Genes Involved in Multidrug Resistance and Metastasis 103
Longitudinal single-cell transcriptomics reveals distinct patterns of recurrence in acute myeloid leukemia 100
Antiproliferative, antibacterial and antifungal activity of the lichen Xanthoria parietina and its secondary metabolite parietin 99
1,4-Dihydropyridines Active on the SIRT1/AMPK Pathway Ameliorate Skin Repair and Mitochondria! Function and Exhibit Inhibition of Proliferation in Cancer Cells 98
17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells 95
Carprofen Analogues as Sirtuin Inhibitors: Enzyme and Cellular Studies 94
Feijoa sellowiana derived natural Flavone exerts anti-cancer action displaying HDAC inhibitory activities 93
Two novel SIRT1 activators, SCIC2 and SCIC2.1, enhance SIRT1-mediated effects in stress response and senescence 93
Cannabinoid receptor 1 influences chromatin remodeling in mouse spermatids by affecting content of transition protein 2 mRNA and histone displacement 89
Forskolin potentiates the effects of GSKJ4 in human acute myeloid leukemia cells through Protein Kinase A pathway 89
Natural compounds in epigenetics: A current view. 88
1,3,4-oxadiazole-containing histone deacetylase inhibitors: anticancer activities in cancer cells. 88
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 88
The Role of Ozone Carried by Liposomes in the Therapy of Infectious and Skin-Regenerating Ocular Surface 87
In vivo functional analysis of the mouse estrogen receptor gene promoter: a transgenic mouse model to study tissue specific and developmental regulation of estrogen receptor gene transcription 86
Altered folate receptor 2 expression in uraemic patients on haemodialysis: Implications for folate resistance 86
HIF3A inhibition triggers browning of white adipocytes via metabolic rewiring. 86
Analysis of chromatin-nuclear receptor interactions by laser-chromatin immunoprecipitation. 85
Histone Deacetylase Inhibitors Impair Vasculogenic Mimicry from Glioblastoma Cells 85
Evaluation of histone deacetylases as drug targets in Huntington's disease models. Study of HDACs in brain tissues from R6/2 and CAG140 knock-in HD mouse models and human patients and in a neuronal HD cell model 84
Epigenetic drugs against cancer: an evolving landscape. 83
A genic and epigenetic combination therapy for liver cancer 83
Benzodeazaoxaflavins as sirtuin inhibitors with antiproliferative properties in cancer stem cells 82
Molecular analysis of the apoptotic effects of BPA in acute myeloid leukemia cells 81
Estrogens Modulate Somatostatin Receptors Expression and Synergizes With the Somatostatin Analog Pasireotide in Prostate Cells 81
ATTIVITÀ ANTI-PROLIFERATIVA E DIFFERENZIANTE INDOTTA DAL FRUTTO DI PSIDIUM GUAJAVA IN CELLULE LEUCEMICHE UMANE 80
Comparative gene expression profiling reveals partially overlapping but distinct genomic actions of different antiestrogens in human breast cancer cells 79
Pan-Histone Demethylase Inhibitors Simultaneously Targeting Jumonji C and Lysine Specific Demethylases Display High Anticancer Activities. 79
Novel cinnamyl hydroxyamides and 2-aminoanilides as histone deacetylase inhibitors: apoptotic induction and cytodifferentiation activity 79
Cancer epigenetics: Moving forward 79
Cardiomyogenesis is controlled by the miR-99a/let-7c cluster and epigenetic modifications. 77
A DNA Methyltransferase Modulator Inspired by Peyssonenyne Natural Product Structures. 77
A gradient of 2-arachidonoylglycerol regulates mouse epididymal sperm cell start-up 77
The International Human Epigenome Consortium: A Blueprint for Scientific Collaboration and Discovery 77
Method for the prognosis and or treatment of acute promyelocytic leukemia 76
Bispyridinium Dienes, Histone Deacetylase Inhibitors With Selective Activities 75
ATTIVITA’ ANTITUMORALE DEL FLAVONE NATURALE PURIFICATO DA FEIJOA SELLOWIANA IN CELLULE DI LEUCEMIA MIELOIDE ACUTA 75
BARD1 is a target of miR-19a and miR-19b: a new selective epigenetic therapy for acute myeloid lekaemias? 75
Investigation of the effect of different linker chemotypes on the inhibition of histone deacetylases (HDACs) 74
HDAC2 deregulation in tumorigenesis is causally connected to repression of immune modulation and defense escape. 73
Nuclear size as estrogen-responsive chromatin quality parameter of mouse spermatozoa. 73
Searching for a putative mechanism of tumor-promoting function of RIZ2 in cancer models 73
Inhibition of histone demethylases LSD1 and UTX regulates ERα signaling in breast cancer 72
Characterization of Histone Acetyltransferase-1 in cancer cells 72
Deregulation of new cell death mechanisms in Leukemia 71
ARHGEF3 controls HDACi-induced differentiation via RhoA-dependent pathways in acute myeloid leukemias. 71
A genomic view of estrogen actions in human breast cancer cells by expression profiling of the hormone-responsive transcriptome 71
17ƒÒ-estradiol overcomes a cell cycle block induced by HMG-CoA reductase inhibitors and fosters cell cycle progression without inducing ERK-1 and ERK-2 MAP kinases activation 71
Anti-leukemia activity of chaetocin via death receptor-dependent apoptosis and dual modulation of the histone methyl-transferase SUV39H1. 71
MicroRNA-34a regulates doxorubicin-induced cardiotoxicity in rat 71
Development of 1,2,4-Oxadiazoles as Potent and Selective Inhibitors of the Human Deacetylase Sirtuin 2: Structure-Activity Relationship, X-ray Crystal Structure, and Anticancer Activity 71
RIPK1-targeting in cancer: modulation of programmed cell death process for cancer treatment 71
Metabolic Pathways as a Novel Landscape in Pancreatic Ductal Adenocarcinoma 70
Context-selective death of acute myeloid leukemia cells triggered by the novel hybrid retinoid-HDAC inhibitor MC2392. 70
Laccase treatment impairs bisphenol A-induced cancer cell proliferation affecting estrogen receptor alpha-dependent rapid signals 70
tert-Butylcarbamate-Containing Histone Deacetylase Inhibitors: Apoptosis Induction, Cytodifferentiation, and Antiproliferative Activities in Cancer Cells 70
Glycation of Wild-Type Apomyoglobin Induces Formation of Highly Cytotoxic Oligomeric Species. 70
Breast Cancer Vaccines: New Insights 70
Comment on: LncRNA SBF2-AS1 promotes hepatocellular carcinoma metastasis by regulating EMT and predicts unfavorable prognosis 70
The Ubiquitin Proteasome System in Hematological Malignancies: New Insight into Its Functional Role and Therapeutic Options 70
CBX2 shapes chromatin accessibility promoting AML via p38 MAPK signaling pathway 69
Relationship between genome and epigenome - challenges and requirements for future research. 69
A dual role for Hdac1: oncosuppressor in tumorigenesis, oncogene in tumor maintenance. 69
Study of 1,4-dihydropyridine structural scaffold: discovery of novel sirtuin activators and inhibitors 69
Synthesis and Biological Validation of Novel Synthetic Histone/Protein Methyltransferase Inhibitors 69
EPIGENETIC-BASED DRUGS IN STEM CELL DIFFERENTIATION 69
Time-resolved analysis of DNA-protein interactions in living cells by UV laser pulses 69
Le basi cellulari e molecolari delle malattie per le lauree triennali e magistrali 69
The Pan-Sirtuin Inhibitor MC2494 Regulates Mitochondrial Function in a Leukemia Cell Line 69
Different Approaches to Unveil Biomolecule Configurations and Their Mutual Interactions 69
Effects of novel SGLT2 inhibitors on cancer incidence in hyperglycemic patients:a meta-analysis of randomized clinical trials 69
The class I-specific HDAC inhibitor MS-275 modulates the differentiation potential of mouse embryonic stem cells 68
ATTIVATORI DI SIRTUINE E LORO USI 68
Effect of bisphenol A with or without enzyme treatment on the proliferation and viability of MCF-7 cells 67
PML-RARalpha/RXR Alters the Epigenetic Landscape in Acute Promyelocytic Leukemia 67
Carbamate Prodrug Concept for Hydroxamate HDAC Inhibitors 67
Combined HAT/EZH2 modulation leads to cancer-selective cell death 67
ANALISI ‘WHOLE-GENOME’ DEL TRASCRITTOMA ESTROGENO-RESPONSIVO DI CELLULE TUMORALI DI MAMMELLA MCF-7 E ZR-75.1 67
Novel derivatives of Psammaplin A, a method for their synthesis and their use for prevention and treatment of cancer 67
Epigenetic modulator UVI5008 inhibits MRSA by interfering with bacterial gyrase 67
POLYPHENOLIC EXTRACTS FROM STRAWBERRY CULTIVARS MODULATE INFLAMMATION IN HUMAN LEUKEMIA CELLS 66
Identification of two New Synthetic Histone Deacetylase Inhibitors that Modulate Globin Gene Expression in Erythroid Cells from Normal Donors and Thalassemic Patients 66
Identification of NuRSERY, a New Functional HDAC Complex Composed by HDAC5, GATA1, EKLF and pERK Present in Human Erythroid Cells. 66
AZIONE "TUMORE-SELETTIVA" DEGLI INIBITORI DELLE ISTONE DEACETILASI IN LEUCEMIE MIELOIDI ACUTE 66
The HDAC inhibitor SAHA regulates CBX2 stability via a SUMO-triggered ubiquitin-mediated pathway in leukemia 66
Unexpected and durable response with regorafenib in a metastatic colorectal cancer patient without KDR mutation: A case report 66
Comparative phytochemical characterization, genetic profile, and antiproliferative activity of polyphenol-rich extracts from pigmented tubers of different solanum tuberosum varieties 66
Age-related miRNome landscape of cumulus oophorus cells during controlled ovarian stimulation protocols in IVF cycles 66
Epi-Drugs Targeting RNA Dynamics in Cancer 65
"Shock and kill" effects of class I-selective histone deacetylase inhibitors in combination with the glutathione synthesis inhibitor buthionine sulfoximine in cell line models for HIV-1 quiescence 65
Synthesis and biological properties of novel, uracil-containing histone deacetylase inhibitors 65
Identification and characterization of PKF118-310 as a KDM4A inhibitor 65
TNF-related apoptosis-inducing ligand: Signalling of a 'smart' molecule 65
Totale 9.131
Categoria #
all - tutte 109.812
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.812


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020107 0 0 0 0 0 0 0 0 0 0 58 49
2020/20212.594 223 27 302 177 383 21 380 274 75 324 277 131
2021/20223.123 218 175 288 159 842 76 94 75 116 150 195 735
2022/20235.436 514 205 435 384 465 386 19 242 2.497 46 104 139
2023/20242.495 201 70 107 210 668 315 67 121 34 86 196 420
2024/20256.478 93 135 197 274 1.183 939 1.300 682 823 824 28 0
Totale 24.209